Publications

• A Brighter Red Section.
  Am J Gastroenterol Volume: 116 Page(s): 2316 - 2317
  12/01/2021 Authors: Karsan HA; Saini SD
• Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
  Am J Gastroenterol
  06/23/2020 Authors: Bajaj JS; Brenner DM; Cai Q; Cash BD; Crowell M; DiBaise J; Gallegos-Orozco JF; Gardner TB; Gyawali CP; Ha C
• Welcome to the New Red Section.
  Am J Gastroenterol Volume: 111 Page(s): 4 - 5
  01/01/2016 Authors: Karsan HA; Saini SD
• Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL.
  Qual Life Res Volume: 24 Page(s): 163 - 179
  01/01/2015 Authors: Spiegel BMR; Reid MW; Bolus R; Whitman CB; Talley J; Dea S; Shahedi K; Karsan H; Teal C; Melmed GY
• Management of alcoholic hepatitis: Current concepts.
  World J Hepatol Volume: 4 Page(s): 335 - 341
  12/27/2012 Authors: Karsan HA; Parekh S
• Factors Analysis of Bowel Symptoms in IBS: Guidance for Patient Reported Outcome (PRO) Development
  Volume: 140 Page(s): S605 - S606
  05/01/2011 Authors: Spiegel BM; Bolus RE; Agarwal N; Sayuk GS; Harris LA; Lucak SL; Esrailian E; Chey WD; Lembo A; Karsan HA
• Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials.
  Aliment Pharmacol Ther Volume: 32 Page(s): 1275 - 1291
  11/01/2010 Authors: Spiegel BMR; Bolus R; Agarwal N; Sayuk G; Harris LA; Lucak S; Esrailian E; Chey WD; Lembo A; Karsan H
• Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice.
  Aliment Pharmacol Ther Volume: 32 Page(s): 1192 - 1202
  11/01/2010 Authors: Spiegel BMR; Bolus R; Harris LA; Lucak S; Chey WD; Sayuk G; Esrailian E; Lembo A; Karsan H; Tillisch K
• Patient-Reported Symptom Relief From Current Therapy is a Robust Marker of Illness Severity in IBS
  Volume: 138 Page(s): S119 - S119
  05/01/2010 Authors: Spiegel BM; Bolus RE; Harris LA; Lucak SL; Esrailian E; Chey WD; Lembo A; Karsan HA; Tillisch K; Talley J
• Do IBS Patients Understand the Difference Between Abdominal Pain vs. Discomfort? Implications for Clinical Practice and Clinical Trial Design
  Volume: 138 Page(s): S379 - S379
  05/01/2010 Authors: Spiegel BM; Bolus RE; Harris LA; Lucak SL; Esrailian E; Chey WD; Lembo A; Karsan HA; Tillisch K; Talley J
• Characterizing Abdominal Pain Attributes in IBS: Guidance for Study Inclusion Criteria and Outcome Measurement
  Volume: 138 Page(s): S99 - S100
  05/01/2010 Authors: Spiegel BM; Bolus RE; Harris LA; Lucak SL; Esrailian E; Chey WD; Sayuk GS; Lembo A; Karsan HA; Tillisch K
• Characterizing "Bowel Urgency": Guidance for Outcome Assessment in Patients With Diarrhea Predominant IBS
  Volume: 138 Page(s): S379 - S379
  05/01/2010 Authors: Spiegel BM; Bolus RE; Harris LA; Lucak SL; Esrailian E; Chey WD; Lembo A; Karsan HA; Tillisch K; Talley J
• Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale.
  Aliment Pharmacol Ther Volume: 30 Page(s): 1159 - 1170
  12/01/2009 Authors: Spiegel B; Bolus R; Harris LA; Lucak S; Naliboff B; Esrailian E; Chey WD; Lembo A; Karsan H; Tillisch K
• Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort.
  Am J Gastroenterol Volume: 104 Page(s): 1984 - 1991
  08/01/2009 Authors: Spiegel B; Harris L; Lucak S; Mayer E; Naliboff B; Bolus R; Esrailian E; Chey WD; Lembo A; Karsan H
• A case of Noonan syndrome and Whipple's disease in the same patient.
  World J Gastroenterol Volume: 15 Page(s): 1524 - 1527
  03/28/2009 Authors: Karsan SS; Karsan HA; Karsan AS; McMillen JI
• Euroqol utilities demonstrate excellent validity and responsiveness in IBS: Results from the proof cohort
  Volume: 134 Page(s): A28 - A28
  04/01/2008 Authors: Spiegel BM; Harris LA; Lucak SL; Mayer EA; Naliboff BD; Bolus RE; Esrailian E; Chey WD; Lembo A; Karsan HA
• Measuring IBS patient reported outcomes with a single item numeric rating scale: Results from the PROOF cohort
  Volume: 134 Page(s): A467 - A467
  04/01/2008 Authors: Spiegel BM; Harris LA; Lucak SL; Mayer EA; Naliboff BD; Bolus RE; Esrailian E; Chey WD; Lembo A; Karsan HA
• Predictors of work productivity in irritable bowel syndrome (IBS): Results from the proof cohort
  Volume: 134 Page(s): A28 - A28
  04/01/2008 Authors: Spiegel BM; Harris LA; Lucak SL; Mayer EA; Naliboff BD; Bolus RE; Esrailian E; Chey WD; Lembo A; Karsan HA
• Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0.
  Hepatology Volume: 46 Page(s): 113 - 121
  07/01/2007 Authors: Spiegel BMR; Bolus R; Han S; Tong M; Esrailian E; Talley J; Tran T; Smith J; Karsan HA; Durazo F
• Development and validation of a disease-targeted health-related quality of life (HRQOL) instrument in chronic hepatitis B infection: The HBQOL v1.0
  Volume: 44 Page(s): 567A - 567A
  10/01/2006 Authors: Spiegel BM; Bolus R; Han S; Tong M; Esrailian E; Talley J; Tran T; Smith J; Karsan HA; Durazo F
• Combination endoscopic band ligation and sclerotherapy compared with endoscopic band ligation alone for the secondary prophylaxis of esophageal variceal hemorrhage: a meta-analysis.
  Dig Dis Sci Volume: 50 Page(s): 399 - 406
  02/01/2005 Authors: Karsan HA; Morton SC; Shekelle PG; Spiegel BMR; Suttorp MJ; Edelstein MA; Gralnek IM
• The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage.
  Volume: 99 Page(s): 1306 - 1315
  07/01/2004 Authors: Targownik LE; Spiegel BMR; Dulai GS; Karsan HA; Gralnek IM
• Primary prevention of cirrhosis. Public health strategies that can make a difference.
  Postgrad Med Volume: 115 Page(s): 25 - 30
  01/01/2004 Authors: Karsan HA; Rojter SE; Saab S
• Cost effectiveness of preventing variceal hemorrhage.
  Hepatology Volume: 38 Page(s): 534 - 535
  08/01/2003 Authors: Post AB
• Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective?
  Hepatology Volume: 37 Page(s): 366 - 377
  02/01/2003 Authors: Spiegel BMR; Targownik L; Dulai GS; Karsan HA; Gralnek IM
• Combination endoscopic band ligation and sclerotherapy compared with band ligation alone for the secondary prophylaxis of esophageal variceal hemorrhage: A meta-analysis.
  Volume: 36 Page(s): 513A - 513A
  10/01/2002 Authors: Karsan HA; Morton SC; Suttorp MJ; Shekelle PG; Edelstein M; Gralnek IM
• Do transjugular intrahepatic portosystemic shunts (TIPS) for refractory ascites really work?.
  Volume: 36 Page(s): 533A - 533A
  10/01/2002 Authors: Karsan HA; Lee C; Dong PR; Durazo F; Saab S; Han SHB
• Is universal screening endoscopy in cirrhosis cost-effective?
  Volume: 122 Page(s): A681 - A681
  04/01/2002 Authors: Spiegel BMR; Targownik L; Karsan HA; Gralnek IM
• The cost effectiveness of hepatic venous pressure gradient (HVPG) monitoring in prevention of recurrent variceal bleeding (RVB)
  Volume: 122 Page(s): A79 - A79
  04/01/2002 Authors: Targownik L; Spiegel BMR; Karsan HA; Gralnek IM
• Is universal screening endoscopy in cirrhosis cost-effective?
  Volume: 55 Page(s): AB85 - AB85
  04/01/2002 Authors: Spiegel BMR; Targownik L; Karsan HA; Gralnek IM